Respiratory Oxygen Delivery Devices Market Size & Growth Forecast 2027–2036, By Segments (End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Respiratory Oxygen Delivery Devices Market size was valued at USD 15.7 billion in 2026 and is anticipated to grow at a 7.51% CAGR from 2027 to 2036, crossing USD 32.39 billion by 2036. The industry revenue for 2027 is calculated at USD 16.69 billion.
Get more details on this report
Request Free Sample ReportRespiratory Oxygen Delivery Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to established oxygen therapy infrastructure, mature reimbursement systems, and consistent device utilization across hospitals, homecare, and long-term care settings.
- Asia Pacific is projected to grow at a 9.04% CAGR, supported by expanding healthcare networks, respiratory care capacity, and demand for cost-effective oxygen solutions.
Segment Momentum
- Hospitals held a 54.35% share in 2026 due to continuous demand for oxygen therapy across emergency departments, intensive care units, inpatient care, and post-operative respiratory support settings.
- Venturi masks are the fastest-growing product segment because they enable more precise oxygen concentration delivery, making them increasingly preferred for patients requiring carefully controlled respiratory support.
Market Expansion Drivers
- Rising prevalence of COPD, asthma, and RSV increasing oxygen therapy demand globally.
- Expanding elderly population driving long-term adoption of respiratory support technologies.
- Growing preference for portable home-based oxygen concentrators accelerating outpatient respiratory care adoption.
Leading Market Participants
- Prominent players in the respiratory oxygen delivery devices market include Koninklijke Philips N.V. (Netherlands), ResMed Inc. (United States), Medtronic plc (Ireland), Masimo Corporation (United States), Chart Industries, Inc. (United States), Invacare Corporation (United States), Drive DeVilbiss Healthcare (United States), Air Liquide S.A. (France), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Smiths Medical (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 15.7 billion
- 2027 Estimated Market Size: USD 16.69 billion.
- Projected Market Size: USD 32.39 billion by 2036
- Growth Forecast: 7.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Oxygen Masks (Product)
- Emerging Opportunity Segment: Hospitals (End-use) | Venturi Masks (Product)
Market Growth Drivers and Industry Trends
Rising prevalence of COPD, asthma, and RSV increasing oxygen therapy demand globally
The increasing prevalence of respiratory conditions such as COPD, asthma, and RSV is strengthening demand for oxygen therapy, supporting the respiratory oxygen delivery devices market growth across hospital and home-care settings. Patients experiencing impaired respiratory function may require supplemental oxygen as part of clinical management, creating sustained requirements for devices that can deliver oxygen safely and consistently. Healthcare providers are therefore relying on oxygen delivery technologies across different stages of respiratory care, from acute treatment environments to longer-term support.
Expanding elderly population driving long-term adoption of respiratory support technologies
An expanding elderly population is contributing to the respiratory oxygen delivery devices market as older adults are more likely to require ongoing management of respiratory conditions and supportive care technologies. Increasing demand for long-term respiratory assistance is encouraging healthcare providers and caregivers to adopt oxygen delivery systems suited to extended use and varying levels of patient mobility. Devices that can support dependable oxygen administration across clinical and residential environments are becoming increasingly relevant as healthcare systems manage the needs of aging populations.
Growing preference for portable home-based oxygen concentrators accelerating outpatient respiratory care adoption
Growing preference for portable, home-based oxygen concentrators is changing how respiratory support is delivered and will propel the respiratory oxygen delivery devices market by enabling more patients to receive oxygen therapy outside traditional clinical settings. Portable systems provide greater flexibility for individuals requiring supplemental oxygen while reducing dependence on stationary equipment and repeated facility-based care. Their suitability for home use and mobility can support outpatient treatment models, allowing patients to integrate respiratory therapy more easily into daily routines while healthcare providers manage longer-term care remotely.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of COPD, asthma, and RSV increasing oxygen therapy demand globally | 2.00% | Moderate | North America, Asia Pacific | High | Near Term |
| Expanding elderly population driving long-term adoption of respiratory support technologies | 1.70% | Moderate | Asia Pacific, Europe | High | Mid Term |
| Growing preference for portable home-based oxygen concentrators accelerating outpatient respiratory care adoption | 1.50% | Low | North America, Asia Pacific | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America led the respiratory oxygen delivery devices market, holding the largest share in 2026, owing to its advanced healthcare infrastructure, high adoption of respiratory care technologies, and strong emphasis on managing chronic and acute respiratory conditions. The region benefits from established hospital and home-care networks that support the use of oxygen delivery equipment across different stages of treatment. Growing demand for respiratory support among aging populations, combined with continued investment in healthcare technology and home-based care, is supporting the adoption of increasingly accessible and patient-oriented oxygen delivery solutions. Strong clinical awareness and established reimbursement and care-delivery frameworks further contribute to the region's sustained market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to be the fastest-growing region, supported by expanding healthcare access, improving hospital infrastructure, and increasing recognition of the need for effective respiratory disease management. Rising healthcare investment is enabling greater availability of respiratory care equipment, while urbanization and changing demographic patterns are contributing to higher demand for healthcare services. The gradual expansion of home healthcare and remote care models is also creating opportunities for oxygen delivery devices outside traditional hospital settings. As healthcare systems strengthen diagnostic and treatment capabilities, greater adoption of respiratory support technologies is expected to drive the region's growth trajectory.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Care OptimizationGermany is emphasizing respiratory oxygen delivery devices that support efficient hospital care and expanding home healthcare services. The country prioritizes reliable oxygen delivery technologies that improve patient comfort while meeting stringent clinical performance requirements.
France 🇫🇷
Patient-Centered Oxygen CareFrance is strengthening the respiratory oxygen delivery devices market through broader adoption of home oxygen therapy and improved chronic respiratory care. Healthcare providers in France focus on reliable, comfortable devices that simplify long-term patient management and clinical follow-up.
Italy 🇮🇹
Community Care IntegrationItaly is expanding the use of respiratory oxygen delivery devices to support community-based care for patients with chronic respiratory conditions. The country prioritizes practical oxygen therapy systems that improve accessibility, ease of use, and continuity of care beyond hospital settings.
Japan 🇯🇵
Portable Therapy SolutionsJapan continues adopting compact respiratory oxygen delivery devices that align with home healthcare expansion and long-term respiratory disease management. Healthcare providers in Japan focus on dependable, easy-to-use systems that support patient mobility and continuous treatment.
South Korea 🇰🇷
Connected Respiratory SupportSouth Korea is integrating respiratory oxygen delivery devices with digital healthcare initiatives and advanced patient monitoring systems. The country emphasizes portable equipment and connected respiratory solutions that improve treatment management across hospitals and home care environments.
United States 🇺🇸
Home Respiratory CareThe U.S. respiratory oxygen delivery devices market is supported by growing demand for home-based respiratory management and long-term oxygen therapy. Healthcare providers in the U.S. prioritize portable, connected, and patient-friendly devices that improve treatment adherence across care settings.
Segment Leadership and Growth Trends
Respiratory Oxygen Delivery Devices Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
The hospitals segment dominated the respiratory oxygen delivery devices market in 2026, accounting for a 54.35% share, and also represented the fastest-growing end-use category. Hospitals remain major users of oxygen delivery devices because they manage patients requiring respiratory support across emergency care, critical care, surgery, and inpatient treatment. The need for reliable oxygen administration and continuous respiratory monitoring makes these devices integral to hospital care pathways. Rising demand for respiratory treatment, increasing hospital capacity, and greater emphasis on effective patient management continue to support strong adoption of oxygen delivery equipment in hospital settings.
Product Segment Analysis: Oxygen Masks (Largest Segment) vs Venturi Masks (Fastest-Growing Segment)
Oxygen masks held the largest share of the respiratory oxygen delivery devices market in 2026 at 38.12%, supported by their broad use in healthcare settings for delivering supplemental oxygen to patients with varying respiratory needs. Their straightforward design, ease of application, and suitability for routine oxygen therapy make them a widely utilized option across hospitals and other care environments. Continued demand for accessible respiratory support equipment and the need for dependable oxygen delivery during acute and ongoing care reinforce the segment's leading position.
Venturi masks are emerging as the fastest-growing product category as healthcare providers increasingly require controlled and precise oxygen delivery for patients whose treatment depends on carefully regulated oxygen concentrations. Their ability to provide a more consistent oxygen concentration makes them particularly useful in situations where excessive oxygen administration may create clinical concerns. Greater emphasis on individualized respiratory care and precise oxygen management is supporting increased adoption of venturi masks across healthcare facilities.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Outpatient Facilities, Home Care | Hospitals | Hospitals |
| Product | Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others | Oxygen Masks | Venturi Masks |
Competitive Landscape and Market Positioning
Leading companies in the respiratory oxygen delivery devices market:
1. Koninklijke Philips N.V. (Netherlands)
2. ResMed Inc. (United States)
3. Medtronic plc (Ireland)
4. Masimo Corporation (United States)
5. Chart Industries Inc. (United States)
6. Invacare Corporation (United States)
7. Drive DeVilbiss Healthcare (United States)
8. Air Liquide S.A. (France)
9. Fisher & Paykel Healthcare Corporation Limited (New Zealand)
10. Smiths Medical (United States)
The respiratory oxygen delivery devices market is experiencing growth through the introduction of portable and digitally connected respiratory support systems. Manufacturers are focusing on improving patient comfort, monitoring accuracy, and homecare compatibility across oxygen therapy solutions. Advancements in telehealth integration and lightweight device design are also strengthening market differentiation.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Koninklijke Philips N.V. (Netherlands) | |||||||
| ResMed Inc. (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Masimo Corporation (United States) | |||||||
| Chart Industries Inc. (United States) | |||||||
| Invacare Corporation (United States) | |||||||
| Drive DeVilbiss Healthcare (United States) | |||||||
| Air Liquide S.A. (France) | |||||||
| Fisher & Paykel Healthcare Corporation Limited (New Zealand) | |||||||
| Smiths Medical (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Respiratory Oxygen Delivery Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Oxygen Source | Oxygen Concentrators, Compressed Oxygen Cylinders, Liquid Oxygen Systems, Centralized Medical Oxygen Systems |
| Patient Population | Adult Patients, Pediatric Patients, Neonatal Patients |
| Distribution Channel | Direct Sales, Medical Device Distributors, Retail & Specialty Pharmacies, Online Channels |
Respiratory Oxygen Delivery Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Hospital Oxygen Infrastructure Readiness Assessment |
|
| Home Oxygen Therapy Adoption and Patient Pathway Analysis |
|
| Tender and Institutional Procurement Intelligence |
|
Need a different cut of the data?
Request Custom ResearchHow big is the respiratory oxygen delivery devices market?
How is the respiratory oxygen delivery devices industry projected to perform over the next decade?
How is the growing burden of respiratory diseases influencing purchasing trends in the respiratory oxygen delivery devices market?
Why are portable oxygen concentrators driving outpatient adoption in the respiratory oxygen delivery devices market?
Why are hospitals the largest end-use segment in the respiratory oxygen delivery devices market?
Which product segment is growing fastest in the respiratory oxygen delivery devices market?
Why is North America the leading region for respiratory oxygen delivery devices?
How is Asia Pacific accelerating growth in oxygen delivery devices?
Who are the major participants shaping the respiratory oxygen delivery devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization